Genotoxicity of Enflurane in Human Peripheral Blood Lymphocytes Studied in vivo by Single Cell Gel Electrophoresis.
10.4097/kjae.2004.47.2.162
- Author:
Se Hyun LEW
1
;
Dong Won KIM
;
Jung Kook SUH
;
Ik Sang SEUNG
;
Jae Chul SHIM
;
Mi Ae CHEONG
;
Jang Hwan PARK
Author Information
1. Department of Anesthesiology and Pain Medicine, Hanyang University College of Medicine, Seoul, Korea. dongwkim@hanyang.ac.kr
- Publication Type:Original Article
- Keywords:
DNA;
enflurane;
lymphocyte;
single cell gel electrophoresis
- MeSH:
Anesthesia;
Cell Death;
Comet Assay;
DNA;
DNA Damage;
Electrophoresis*;
Enflurane*;
Humans*;
Inhalation;
Lymphocytes*;
Nitrous Oxide;
Olea;
Oxygen;
Vecuronium Bromide
- From:Korean Journal of Anesthesiology
2004;47(2):162-166
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The alkaline single cell gel electrophoresis comet assay was applied to study the genotoxic properties of enflurane on the human peripheral blood lymphocytes (PBL) of cancer patients before and during anesthesia as compared to an non-cancer control group. Method: The cancer group consisted of 24 patients (aged 15-77 years), while the control group consisted of 14 trauma individuals (aged 20-81 years). After anesthesia induction (thiopental 4 mg/kg and vecuronium 0.1 mg/kg), it was maintained by enflurane inhalation; 1-2 minimal alveolar concentration in oxygen - nitrous oxide mixture. Venous blood samples were obtained before the induction of anesthesia, and after 60 and 120 min of anesthesia. The comet assay detects DNA damage, such as strand breaks and alkaline labile sites induced directly by genotoxic agents, and DNA degradation due to cell death. Fifty cells from each sample were examined and Olive tail moments (OTM) were calculated using Komet 4TM software. RESULTS: OTM values were no different between controls and patients before anesthesia. However, the OTMs of blood sampled from cancer patients at 60 (7.97 +/- 1.83) and 120 min (7.86 +/- 2.05), and from trauma patients at 120 min (8.04 +/- 1.32) of anesthesia were significantly increased. CONCLUSIONS: In immunocompromised cancer patients, we suggest the existence of a higher risk of an association DNA damage and enflurane exposure.
